Pharmaceutical · Fiscal year end Mar 31

SANTEN PHARMACEUTICAL CO.,LTD.

4536

参天製薬株式会社

FIGI BBG000BJYV904536.T4536 JPCorp. no. 5120001051819

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-10

For the first half of the fiscal year to 2026-03: Revenue ¥137.9 billion (-5.8% YoY), Profit before tax ¥17.6 billion (-26.0% YoY), Net income ¥13.9 billion (-25.7% YoY).

	This period	Year on year
Revenue	¥137.9bn	-5.8%
Profit before tax	¥17.6bn	-26.0%
Net profit to owners	¥13.9bn	-25.7%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4536/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2026-03-31

Revenue: ¥291.6bn
Net income: ¥37.4bn
ROE: 12.8%
Equity ratio: 70.2%
Dividend / share: ¥38
Employees: 3,968

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2026-03-31	¥291.6bn	¥37.4bn	¥423.0bn	¥297.0bn	12.8%	¥114.04	¥43.5bn
2025-03-31	¥300.0bn	¥36.3bn	¥409.3bn	¥286.2bn	12.2%	¥103.98	¥60.9bn
2024-03-31	¥302.0bn	¥26.6bn	¥435.7bn	¥306.1bn	8.9%	¥72.59	¥72.6bn
2023-03-31	¥279.0bn	−¥14.9bn	¥421.2bn	¥294.0bn	-4.7%	¥-38.6	¥37.1bn
2022-03-31	¥266.3bn	¥27.2bn	¥460.0bn	¥337.5bn	8.4%	¥68.07	¥46.0bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31

Metric	Value	Percentile among listed companies
ROE, %	12.8	71
Ordinary margin	0.1627	84.7
Equity ratio, %	70.2	75
Revenue growth	-0.0279	16.2
Net income growth	0.0307	38.9
Operating cash flow / assets	0.1028	74.3

Policy-uncertainty measure1.09 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Regulation 2

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change +1.02pt in 90 days; 5.9% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4536/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Share buyback, report to —: ¥31.9bn acquired of a ¥35.0bn limit. /v1/companies/4536/buybacks

Internal control, 2026-06-18: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Latest voting result: 2026-06-23 · 剰余金処分の件 · passed. /v1/companies/4536/voting

Ownership changes

All companies →

2026-10-26

Purpose change+1.02pt

Silchester International Investors LLP changed its stated purpose for holding SANTEN PHARMACEUTICAL CO.,LTD. (4536): may_make_proposals -> may_make_proposals, shareholder_value_engagement.

S100Z9VHFiler profile Original filing (PDF, Japanese)
2026-10-26

Increase+1.02pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 10.25% from 9.23%.

S100Z9VHFiler profile Original filing (PDF, Japanese)
2026-10-26

Threshold

Holdings of Silchester International Investors LLP in SANTEN PHARMACEUTICAL CO.,LTD. (4536) moved above 10% (9.23% -> 10.25%).

S100Z9VHFiler profile Original filing (PDF, Japanese)
2025-10-08

Increase+1.02pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 9.23% from 8.21%.

S100WU0GFiler profile Original filing (PDF, Japanese)
2025-09-22

Increase+1.08pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 8.21% from 7.13%.

S100WQ8QFiler profile Original filing (PDF, Japanese)
2025-09-19

Increase+0.34pt

Sumitomo Mitsui Trust Asset Management Co.,Ltd. raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 5.54% from 5.20%.

S100WPCCFiler profile Original filing (PDF, Japanese)
2025-03-24

Increase+0.03pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 7.13% from 7.10%.

S100VFQFFiler profile Original filing (PDF, Japanese)
2025-03-05

Increase+1.02pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 7.10% from 6.08%.

S100VCI4Filer profile Original filing (PDF, Japanese)
2025-02-07

Increase+1.06pt

Silchester International Investors LLP raised holdings in SANTEN PHARMACEUTICAL CO.,LTD. (4536) to 6.08% from 5.02%.

S100V7FCFiler profile Original filing (PDF, Japanese)
2024-12-05

New 5% stake

BlackRock Japan Co., Ltd. disclosed a 5.27% stake in SANTEN PHARMACEUTICAL CO.,LTD. (4536), crossing the 5% reporting threshold.

S100UW8XFiler profile Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
Silchester International Investors LLP	2024-03-22 – 2026-10-23	+15,708,100	+4.50pt	¥1,547.38	¥1,369–1,891
Massachusetts Financial Services Company	2021-10-05 – 2022-03-29	-1,023,131	−0.26pt	¥1,417.02	¥1,235–1,638
MFSインベストメント・マネジメント株式会社	2022-03-24 – 2022-03-24	-56,300	−0.01pt	¥1,317	¥1,317–1,317

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4536/trades.

5% filings

Large shareholding reports on 4536

Filed	Filer	Stake	Change	Stated purpose
2026-10-26	Silchester International Investors LLP	10.25%	+1.02pt	may make proposals shareholder value engagement
2025-10-08	Silchester International Investors LLP	9.23%	+1.02pt	may make proposals
2025-09-22	Silchester International Investors LLP	8.21%	+1.08pt	may make proposals
2025-09-19	Sumitomo Mitsui Trust Asset Management Co.,Ltd.	5.54%	+0.34pt	—
2025-03-24	Silchester International Investors LLP	7.13%	+0.03pt	may make proposals
2025-03-05	Silchester International Investors LLP	7.10%	+1.02pt	may make proposals
2025-02-07	Silchester International Investors LLP	6.08%	+1.06pt	may make proposals
2024-12-05	BlackRock Japan Co., Ltd.	5.27%	—	pure investment
2024-10-18	Black Creek Investment Management, Inc.	3.77%	−1.44pt	—
2024-07-29	Mitsubishi UFJ Financial Group, Inc.	5.37%	+0.21pt	strategic holding

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 7 issues
Book value: ¥10.9bn
Sold in the year: ¥572m 2 issues
Bought in the year: — — issues
Mutual, both reports: 7
Held by listed cos.: 12

Holds	Book value	Shares vs. prior year	Mutual
ONO PHARMACEUTICAL CO., LTD. 4528	¥8,680m	0.0%	both reports
MEDIPAL HOLDINGS CORPORATION 7459	¥1,098m	0.0%	both reports
Mitsubishi UFJ Financial Group, Inc. 8306	¥505m	0.0%	both reports
SEIKAGAKU CORPORATION 4548	¥303m	0.0%	both reports
VITAL KSK HOLDINGS,INC. 3151	¥188m	0.0%	both reports
OHKI HEALTHCARE HOLDINGS CO.,LTD. 3417	¥66m	0.0%	no
株式会社ほくやく・竹山ホールディングス	¥15m	0.0%	stated
TOHO HOLDINGS CO.,LTD. 8129	—	sold all	both reports
SUZUKEN CO.,LTD. 9987	—	sold all	both reports

Held by: Mitsubishi UFJ Financial Group, Inc. 8306, ONO PHARMACEUTICAL CO., LTD. 4528, SUZUKEN CO.,LTD. 9987, Tokio Marine Holdings, Inc. 8766, SEIKAGAKU CORPORATION 4548, VITAL KSK HOLDINGS,INC. 3151, MEDIPAL HOLDINGS CORPORATION 7459, DAI-DAN CO.,LTD. 1980, ASAHI PRINTING CO.,LTD. 3951, VITAL KSK HOLDINGS,INC. 3151, Astena Holdings Co., Ltd. 8095, DAI-DAN CO.,LTD. 1980 and 2 more

Purposes, all holdings and mutual flags via /v1/companies/4536/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31

Shareholder	Shares	Ratio
日本マスタートラスト信託銀行株式会社（信託口）	51,649,000	16.05%
株式会社日本カストディ銀行（信託口）	19,488,000	6.06%
NORTHERN TRUST CO.（AVFC）RE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE EQUITY TRUST	13,443,000	4.18%
日本生命保険相互会社	10,662,000	3.31%
NORTHERN TRUST CO. (AVFC) RE U.S. TAX EXEMPTED PENSION FUNDS	9,008,000	2.80%
GOVERNMENT OF NORWAY	8,580,000	2.67%
株式会社三菱UFJ銀行	6,989,000	2.17%
STATE STREET BANK AND TRUST COMPANY 505001	6,586,000	2.05%
JPモルガン証券株式会社	6,453,000	2.01%
小野薬品工業株式会社	6,204,000	1.93%

U.S. funds holding 4536

SEC Form N-PORT, reports to 2026-07-31

113 U.S. funds held 30,663,441 shares worth $374.7m.

Fund	Shares	Value	% of fund	As of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS	4,490,867	$53.0m	0.008%	2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	2,986,902	$39.2m	0.012%	2026-06-30
iShares Core MSCI EAFE ETF iShares Trust	2,212,000	$26.1m	0.014%	2026-07-31
Old Westbury Small & Mid Cap Strategies Fund Old Westbury Funds Inc	1,842,207	$21.7m	0.235%	2026-07-31
College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund	1,335,800	$17.5m	0.012%	2026-06-30

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4536
GET /v1/companies/4536/financials
GET /v1/companies/4536/details
GET /v1/companies/4536/segments
GET /v1/companies/4536/voting
GET /v1/companies/4536/tender-offers
GET /v1/companies/4536/indicators
GET /v1/companies/4536/earnings-releases
GET /v1/events?ticker=4536
GET /v1/companies/4536/trades         
GET /v1/companies/4536/cross-holdings 
GET /v1/companies/4536/brief

Plans from $9 a month · Documentation